Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Atea Pharmaceuticals
AVIR
$249M
| $5.51M | ﹤0.01% |
1,807,912
+82,183
| +5% | +$251K |
|
2652
Weibo
WB
$3B
| $5.51M | ﹤0.01% |
504,875
+10,965
| +2% | +$120K |
|
|
VTNR
2653
DELISTED
Vertex Energy, Inc
VTNR
| $5.49M | ﹤0.01% |
1,620,139
+86,789
| +6% | +$294K |
|
|
AGTI
2654
DELISTED
Agiliti, Inc.
AGTI
| $5.49M | ﹤0.01% |
692,795
+55,115
| +9% | +$437K |
|
2655
HighPeak Energy
HPK
$899M
| $5.48M | ﹤0.01% |
385,015
+16,123
| +4% | +$230K |
|
2656
Arhaus
ARHS
$1.52B
| $5.47M | ﹤0.01% |
461,793
+27,216
| +6% | +$323K |
|
2657
Vivid Seats
SEAT
$110M
| $5.46M | ﹤0.01% |
43,157
+10,211
| +31% | +$1.29M |
|
2658
Terns Pharmaceuticals
TERN
$633M
| $5.46M | ﹤0.01% |
840,459
+52,344
| +7% | +$340K |
|
2659
Entravision Communication
EVC
$226M
| $5.44M | ﹤0.01% |
1,305,215
+12,243
| +0.9% | +$51.1K |
|
2660
Destination XL Group
DXLG
$80.3M
| $5.44M | ﹤0.01% |
1,235,467
+52,948
| +4% | +$233K |
|
2661
OptimizeRx
OPRX
$322M
| $5.42M | ﹤0.01% |
378,513
+35,417
| +10% | +$507K |
|
2662
Sutro Biopharma
STRO
$74.3M
| $5.4M | ﹤0.01% |
1,259,237
+62,085
| +5% | +$266K |
|
2663
Costamare
CMRE
$1.48B
| $5.4M | ﹤0.01% |
518,564
+12,759
| +3% | +$133K |
|
2664
Primis Financial Corp
FRST
$269M
| $5.4M | ﹤0.01% |
426,337
+20,470
| +5% | +$259K |
|
2665
BayCom
BCML
$324M
| $5.39M | ﹤0.01% |
228,542
+4,298
| +2% | +$101K |
|
2666
El Pollo Loco
LOCO
$304M
| $5.37M | ﹤0.01% |
608,857
+30,401
| +5% | +$268K |
|
2667
Potbelly
PBPB
$514M
| $5.37M | ﹤0.01% |
514,959
+19,974
| +4% | +$208K |
|
2668
Holley
HLLY
$370M
| $5.36M | ﹤0.01% |
1,100,785
+45,636
| +4% | +$222K |
|
2669
Astria Therapeutics
ATXS
$419M
| $5.36M | ﹤0.01% |
697,215
+198,367
| +40% | +$1.52M |
|
2670
Rigel Pharmaceuticals
RIGL
$681M
| $5.36M | ﹤0.01% |
369,270
+14,560
| +4% | +$211K |
|
2671
Teekay
TK
$722M
| $5.35M | ﹤0.01% |
748,633
-15,778
| -2% | -$113K |
|
2672
eHealth
EHTH
$122M
| $5.33M | ﹤0.01% |
611,186
+37,120
| +6% | +$324K |
|
2673
Mersana Therapeutics
MRSN
$35.6M
| $5.33M | ﹤0.01% |
91,885
+5,578
| +6% | +$324K |
|
2674
Kodak
KODK
$486M
| $5.32M | ﹤0.01% |
1,364,893
+64,450
| +5% | +$251K |
|
|
PINE
2675
Alpine Income Property Trust
PINE
$208M
| $5.32M | ﹤0.01% |
314,548
+10,836
| +4% | +$183K |
|